Embody review
Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation.
Est. first month
From $79/mo (all doses, compounded)
- Semaglutide
- From $79/mo (all doses, compounded)
- Tirzepatide
- From $129/mo (all doses, compounded)
- Coverage
- All 50 states
- Brand-name
- Compounded only
The Value Score card
Embody scored on our six published factors. See the methodology.
Why it's a deal
- Among the lowest flat rates in the compounded segment — $79/mo semaglutide and $129/mo tirzepatide injection at every dose
- Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
- Available in all 50 states with no insurance friction
- 24/7 unlimited clinician messaging and dose-adjustment support included
- Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine
Read the fine print
- The $79 flat rate relies on an auto-applied promo 'locked forever' — list price in the terms is $199/mo and reviewers allege the lock isn't honored
- Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
- Pharmacy partners not publicly named — compounding source transparency is limited
- Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate
The bottom line
Best for: Shoppers who want low flat-rate compounded GLP-1 pricing at every dose. Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation.
Ranked #33 of 395 programs we track — see our #1 deal, CoreAge Rx, for comparison.
Compare with other deals
The programs scoring closest to Embody, out of 394 others we track.
Shopping Embody against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Embody, and every program that undercuts or outscores it is ranked on the Embody alternatives board.
- $145/moTelos Rx— Among the lowest published GLP-1 entry prices anywhere — microdosed semaglutide from $49/mo and tirzepatide from $99/mo — on a deep needle-free and oral menu, but the rock-bottom rates require a 6–12 month commitment, so the real month-to-month cost runs higher.85/100
- $199/moMadeMed— Not the cheapest, but the most honest about what a titrated dose actually costs.85/100
- $119/moBelle Health— Belle Health is a national DTC telehealth platform offering compounded semaglutide and tirzepatide with flat-rate pricing — the same monthly cost at every dose, with no escalation surcharge as you titrate up.85/100
- From $99/mo (starting dose, plus a separate fee, compounded)Jyra Health— Jyra Health is an online weight-loss and longevity telehealth clinic offering compounded GLP-1 — semaglutide from $99/mo and tirzepatide from $133/mo (limited time) — prescribed by board-certified providers…85/100
- $199/moShedRx— Good headline prices and four routes to a GLP-1 — but the cheapest numbers it advertises need a year-long commitment.84/100
- $199/moyourEra— A transparent, publicly priced GLP-1 program — both molecules at $199/$299 with no hidden quiz-wall — that's honest and mid-market rather than rock-bottom.84/100
More programs we track (24)
- #1 CoreAge Rx93
- #2 Ondra Health92
- #4 Vitara RX91
- #5 Gimme Care91
- #7 Alan Meds90
- #3 Trimi Health89
- #10 Precision Telemed89
- #11 bmiMD89
- #12 Care Clinics89
- #6 Oak88
- #16 Live Vital88
- #17 AmberHealth88
- #18 Fresh Day Meds88
- #8 Sesame Care87
- #9 Strut Health87
- #22 EverSlim87
- #23 NewSelf87
- #24 Vaylen87
- #25 Mint Med87
- #13 HealthRX86
- #14 RxSpan MD86
- #15 Sprout Health86
- #28 Bionomy Health86
- #29 BetterMe Rx86
364 more are reviewed too — see every GLP-1 program we track, ranked.
Pricing and coverage on this page were read from Embody's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Embody's site. Not medical advice; see our disclosure.